Shandong Lukang PharmaceuticalLtd (600789) Stock Overview
Operates as a pharmaceutical company in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
600789 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shandong Lukang Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.25 |
| 52 Week High | CN¥11.97 |
| 52 Week Low | CN¥8.79 |
| Beta | 0.19 |
| 1 Month Change | 1.20% |
| 3 Month Change | -7.41% |
| 1 Year Change | -1.28% |
| 3 Year Change | 36.63% |
| 5 Year Change | 11.04% |
| Change since IPO | 262.00% |
Recent News & Updates
Recent updates
We Think Shandong Lukang PharmaceuticalLtd (SHSE:600789) Is Taking Some Risk With Its Debt
Jan 16
A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb
Nov 11We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings
Nov 05Does Shandong Lukang PharmaceuticalLtd (SHSE:600789) Have A Healthy Balance Sheet?
Sep 26Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Price Is Out Of Tune With Earnings
Aug 21Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?
Jun 03Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) Surges 26% Yet Its Low P/E Is No Reason For Excitement
May 06Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Solid Profits Have Weak Fundamentals
Apr 03Shareholder Returns
| 600789 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.4% | 0.2% | 1.7% |
| 1Y | -1.3% | 26.0% | 35.4% |
Return vs Industry: 600789 underperformed the CN Pharmaceuticals industry which returned 27.1% over the past year.
Return vs Market: 600789 underperformed the CN Market which returned 36% over the past year.
Price Volatility
| 600789 volatility | |
|---|---|
| 600789 Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 600789 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600789's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1966 | 6,388 | Kun Dong | www.lkpc.com |
Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products.
Shandong Lukang Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600789 fundamental statistics | |
|---|---|
| Market cap | CN¥9.64b |
| Earnings (TTM) | CN¥188.75m |
| Revenue (TTM) | CN¥6.19b |
Is 600789 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600789 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.19b |
| Cost of Revenue | CN¥4.78b |
| Gross Profit | CN¥1.41b |
| Other Expenses | CN¥1.22b |
| Earnings | CN¥188.75m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Apr 25, 2026
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 22.82% |
| Net Profit Margin | 3.05% |
| Debt/Equity Ratio | 73.2% |
How did 600789 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 08:43 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Lukang Pharmaceutical Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.